Home About Login Register Search Archives Announcements

 

Aim and Scope

To provide communication and information exchanging platforms for a broad audience of oncologists, surgeons, medical researchers and professionals working in the field.

Editor-in-Chief

Prof. Dr. Kwong-Kwok Wong
The University of Texas MD Anderson Cancer Center

Indexing and Archiving

Advances in Modern Oncology Research is currently indexed in:

-CAS

  • -CNKI
  • -J-gate
  • -Directory of Open Access Journals (DOAJ)
  • -Google Scholar


AMOR is archived by Portico and the National Library Board of Singapore.

User
Submit Your Manuscript

Downloads

Manuscript Submission Template

ICMJE Conflict of Interest Form

Events

Article Tools
Print this article
Indexing metadata
How to cite item
Finding References
Email this article (Login required)
Email the author (Login required)
Post a Comment (Login required)

Tweets by @AMOR_PiscoMed

Keywords bioinformatics breast cancer breast carcinoma cancer case report chemotherapy cisplatin epidemiology immunotherapy mutation non-small cell lung cancer omics oncology ovarian cancer prostate cancer radiotherapy rectal cancer survival targeted therapy therapy treatment
Home > Vol 3, No 6 (2017) > Wijaya

Inherited mutations in BRCA1 and BRCA2 in an unselected multi-ethnic cohort of Asian breast cancer patients and healthy controls from Malaysia

Abstract - 1206 PDF - 477
Eldarina Wijaya, Wei Xiong Wen, Kah Nyin Lai, Jamie Allen, Craig Luccarini, Joanna Lim, Min Min Tan, Shivaani Mariapun, Cheng Har Yip, Nur Aishah Mohd Taib, Alison Dunning, Douglas Easton, Soo Hwang Teo

Abstract


Background: To ascertain the contribution of germline alterations in BRCA1 and BRCA2 in an unselected cohort of Asian breast cancer patients and healthy controls. Methods: Two thousand five hundred and ninety-two invasive breast cancer patients and 2,815 healthy controls were included into our study. Amplicon-based targeted sequencing of exonic and proximal splice site junction regions of 31 known and probable breast cancer susceptibility genes were performed on Fluidigm Access Array system, with sequencing conducted on Illumina HiSeq2500 platform. Variant calling was performed as per GATK recommended best practices and were validated with Sanger sequencing. Results: Comparable BRCA1 and BRCA2 carrier rates were observed among breast cancer patients with frequencies of 57 (2.2%) and 66 (2.5%), respectively. Both BRCA1 and BRCA2 conferred increased breast cancer risk with odds ratio 13.0 (95% Cl: 5.2–32.4) and 12.5 (95% Cl: 5.4–28.9), respectively. BRCA1/2 carriers were more likely to be younger, have family history of breast and/or ovarian cancer, have higher grade tumours and for BRCA1 carriers, they were more likely to have hormone receptor negative breast cancers.  Notably, 45.7% of breast cancer patients fulfilled the NCCN guidelines for recommendation for genetic counselling and genetic testing, and of these, 80% of BRCA1/2 carriers fulfilled the NCCN guidelines.  Conclusion: Taken together, our results show that approximately 5% of unselected Asian breast cancer patients are carriers of germline BRCA1/2 mutations. Our study could provide a framework for genetic breast cancer risk assessment and calibration, and enable risk assessment and management of Asian breast cancer patients attending clinical genetic services.


Keywords


breast cancer; germline BRCA1/2; mutation

Full Text:

PDF


DOI: http://dx.doi.org/10.18282/amor.v3.i6.263

Refbacks

  • There are currently no refbacks.

Comments on this article

  • Multicine Cinemas
    by CarolinaConceição Bonfim (2018-06-20)
  • Assignment Help Tutors
    by voilet taylor (2018-07-04)
View all comments


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Bookmark and Share
                                       

© 2017 by PiscoMed Publishing Pte Ltd